SPACs: Advantages and Disadvantages Versus Normal IPO

Join this session to learn about the rise in SPACs (special purpose acquisition companies) for biotechs interested in going public. Although 2020 is a record year for biotechnology initial public offerings, companies continue to explore different options to raise capital. Experienced executives and capital markets experts will discuss advantages and disadvantages to consider if this is the best approach for your company.